SPECTRAL AI, INC. Cost of Revenue
SPECTRAL AI, INC. (MDAI) reported Cost of Revenue of $2.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-11
- SPECTRAL AI, INC. cost of revenue for the quarter ending 2026-06-30 was $2.41M, a 13.12% decline year-over-year.
- SPECTRAL AI, INC. cost of revenue for the quarter ending 2026-03-31 was $1.96M, a 44.50% decline year-over-year.
- SPECTRAL AI, INC. cost of revenue for the quarter ending 2025-12-31 was $2.24M, a 47.37% decline year-over-year.
- SPECTRAL AI, INC. cost of revenue for the quarter ending 2025-09-30 was $2.17M, a 51.82% decline year-over-year.
- SPECTRAL AI, INC. cost of revenue for fiscal 2025 was $10.72M, a 34.23% decline from fiscal 2024.
- SPECTRAL AI, INC. cost of revenue for fiscal 2024 was $16.31M, a 60.25% increase from fiscal 2023.
- SPECTRAL AI, INC. cost of revenue for fiscal 2023 was $10.18M, a 29.97% decline from fiscal 2022.
- SPECTRAL AI, INC. cost of revenue for fiscal 2022 was $14.53M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.41M 10-Q · filed 2026-08-11 | $4.38M 10-Q · filed 2026-08-11 | $6.62M derived: sum of 3 quarters · filed 2026-08-11 | $8.79M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-13 | $4.20M derived: sum of 2 quarters · filed 2026-05-13 | $6.38M derived: sum of 3 quarters · filed 2026-05-13 | $9.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.41M derived: sum of 2 quarters · filed 2026-03-25 | $7.19M derived: sum of 3 quarters · filed 2026-08-11 | $10.72M 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.17M 10-Q · filed 2025-11-13 | $4.95M derived: sum of 2 quarters · filed 2026-08-11 | $8.48M 10-Q · filed 2025-11-13 | $12.74M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.77M 10-Q · filed 2026-08-11 | $6.31M 10-Q · filed 2026-08-11 | $10.57M derived: sum of 3 quarters · filed 2026-08-11 | $15.08M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $3.54M 10-Q · filed 2026-05-13 | $7.79M derived: sum of 2 quarters · filed 2026-05-13 | $12.30M derived: sum of 3 quarters · filed 2026-05-13 | $16.46M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.76M derived: sum of 2 quarters · filed 2026-03-25 | $12.93M derived: sum of 3 quarters · filed 2026-03-25 | $16.31M 10-K · filed 2026-03-25 |
| 2024-09-30 | $4.51M 10-Q · filed 2025-11-13 | $8.67M derived: sum of 2 quarters · filed 2025-11-13 | $12.05M 10-Q · filed 2025-11-13 | $14.90M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $4.16M 10-Q · filed 2025-08-13 | $7.54M 10-Q · filed 2025-08-13 | $10.40M derived: sum of 3 quarters · filed 2025-08-13 | $12.36M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.38M 10-Q · filed 2025-05-15 | $6.23M derived: sum of 2 quarters · filed 2025-05-15 | $8.20M derived: sum of 3 quarters · filed 2025-05-15 | $10.66M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.82M derived: sum of 2 quarters · filed 2025-03-31 | $7.28M derived: sum of 3 quarters · filed 2025-03-31 | $10.18M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.97M 10-Q · filed 2024-11-06 | $4.43M derived: sum of 2 quarters · filed 2024-11-06 | $7.33M 10-Q · filed 2024-11-06 | $10.91M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $2.46M 10-Q · filed 2024-08-12 | $5.36M 10-Q · filed 2024-08-12 | $8.95M derived: sum of 3 quarters · filed 2024-08-12 | $12.76M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.90M 10-Q · filed 2024-05-09 | $6.49M derived: sum of 2 quarters · filed 2024-05-09 | $10.30M derived: sum of 3 quarters · filed 2024-05-09 | $13.97M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $7.40M derived: sum of 2 quarters · filed 2024-03-29 | $11.08M derived: sum of 3 quarters · filed 2024-03-29 | $14.53M 10-K · filed 2024-03-29 |
| 2022-09-30 | $3.81M 10-Q · filed 2023-11-14 | $7.49M derived: sum of 2 quarters · filed 2023-11-14 | $10.94M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $3.68M 8-K · filed 2023-09-15 | $7.13M 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |